Pre-Filled Syringes and Injectable Drug Devices East Coast Conference 2025

Driving innovations in device design, connectivity and sustainability for advanced parenteral combination products

April 28-30, 2025 - Boston, MA, United States

The 12th Annual Pre-Filled Syringes East Coast Conference will return to Boston in April 2025 to bring you the latest advances in the combination product drug delivery space.

As part of the leading Injectable Drug Delivery Series, the 2025 conference will be bigger and better than ever, bringing you 3 days of expertise, comprising of a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference with morning keynote plenaries and parallel afternoon topic streams addressing the industry’s hottest topics through case studies and industry insights.

This event will not only bring you key insights needed to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in April 2025!

Featured Speakers

  • Aditya Nair, Packaging Engineer, Pfizer
  • Ajit D'Souza, Executive Director, Drug Delivery and Devices, Eli Lilly
  • Alan Stevens, Global Head, Complex Devices and Drug Delivery Systems, AbbVie
  • Alfredo Ricci, CEO, Althena Medical
  • Amardeep Hoonjan, Director Device R&D Lead, Biocompatibility Group, AbbVie
  • Andy Pidgeon, Head of Usability, 42 Technology Limited
  • Bharat Arora, Director, Global Combination Products Quality, Moderna
  • Chris Muenzer, Vice President Innovation and Development, Haselmeier GmbH
  • Confirmed Senior Representative, Biophorum
  • Conor O'Neill, Head of Packaging Development and Design, GSK
  • Daniel Davenport, Associate Director Early Engagement and Deviceability, GSK
  • Dany Doucet, Director Early Engagement and Deviceability, GSK
  • David Vazquez, Head SaMD Legal Manufacturing, Pfizer
  • Duncan Paterson, Senior Director, AstraZeneca
  • Ellie Younger, Associate Principal Engineer, AstraZeneca
  • Fletcher Dix, Sr. Process Characterization and Technology Engineer, Regeneron Pharmaceuticals
  • Frances Pencliffe, Consultant Healthcare Devices Engineer, Cambridge Design Partnership
  • Greg Moakes, EVP, New Business Development, LTS Device Technologies
  • Gretchen Piwinski, Sr Manager Combination Product Development, Regeneron
  • Guangli Hu, Director, Merck & Co., Inc.
  • James P. Wabby, Global Head, Regulatory Affairs - Emerging Device Technologies and Combination Products, AbbVie
  • Jamie Tsung, Director CMC Development, Alnylam Pharmaceuticals
  • Jayne Gavrity, Senior Device Engineer, AstraZeneca
  • Jerzy Wojcik, Vice President, EdgeOne Medical
  • Jia Huang, Associate Director, Merck & Co.
  • Joanita Akole Lamien, Sr. Human Factors Engineer, Regeneron Pharmaceuticals
  • John Merhige, CEO, Credence MedSystems, Inc.
  • Joyce Zhao, Director, Combination Product Development, Takeda Pharmaceuticals
  • Kinsuk Shah, Sr. AD Combination Product Steward, Boehringer Ingelheim
  • Landon Goldfarb, Biomedical Market Manager, Instron
  • Lisa Ray, Executive Director Program Management – Delivery, Device & Connected Solutions, Eli Lilly
  • Mark DeStefano, Director, Combination Products and Device R&D, Teva Pharmaceuticals
  • Mark Hassett, Vice President of Business Development, Credence MedSystems
  • Martin McLoughlin, Head of Device Development, Bristol Myers Squibb
  • Masashi Miura, Researcher, Mitsubishi Gas Chemical Company, Inc
  • Matt Marber, Senior Usability Engineer, Novo Nordisk
  • Max Lerman, Sr. Prin. Consultant / Assoc. Dir. of Technical Learning and Development, Suttons Creek
  • Megan Heft, Director, Device Development, AstraZeneca
  • Moritz Mond, Product Manager, Gerresheimer
  • Nicholas Mandala, VP Medical Device & Combination Product Technology, Pfizer
  • Ning Yu, Executive Director, Device and Combination Product Development, Astria Therapeutics
  • Nolan Dow, Combination Product Development Engineer, Pfizer
  • Paul Reyland, Director of Sales, CCL Healthcare
  • Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals
  • Sarah Fairfield, Associate Director, RA Device and Combination Products Digital Device and Software, AbbVie
  • Soumen Das, Medical Device Qualification Lead & Associate Scientific Fellow, Takeda Pharmaceutical Company Limited
  • Speaker to be confirmed, Crux Product Design Ltd
  • Sriman Banerjee, Head of Packaging Development & CDE, Takeda Pharmaceuticals
  • Steve Badelt, Executive Vice President and Managing Partner, Suttons Creek
  • Subhi Saadeh, Senior Manager, Combination Products QA, Gilead
  • Sujit Basu, Vice President & Head, Pharmaceutical Development, Ionis
  • Theresa Scheuble, Head of Design & Innovation, Johnson & Johnson
  • Yvette Appleby, Senior Manager Project Management, Pfizer

Please fill in your name and email to receive the Conference Agenda of this event.

Venue

Sheraton Boston Hotel
39 Dalton Street,
Boston, MA, USA